Chondroitin Sulfate Proteoglycan 4 and Its Potential As an Antibody Immunotherapy Target across Different Tumor Types. (2017)
Attributed to:
Preclinical efficacy of an antibody of the IgE class against a melanoma-associated antigen
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3389/fimmu.2017.01911
PubMed Identifier: 29375561
Publication URI: http://europepmc.org/abstract/MED/29375561
Type: Journal Article/Review
Volume: 8
Parent Publication: Frontiers in immunology
ISSN: 1664-3224